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KEYWORDS	
	 In	 the	 present	 study,	 synthesis	 of	 transition	metal	 complexes	 of	 DL‐tryptophan	with	metal
precursors	 such	 as	 nickel	 (II)	 and	 cobalt	 (II)	 ions	 in	 water	 under	 refluxing	 conditions	 and
optimization	of	 the	reactions	to	obtain	the	composition	of	complexes	 in	water	solutions	has
been	reported.	The	preparation	and	structural	elucidation	of	the	complexes	was	undertaken
by	using	physico‐chemical,	potentiometric	titration	and	spectroscopic	methods	(UV/Vis,	FT‐IR
and	 XRD).	 Comparisons	 of	 the	 spectral	 measurements	 of	 DL‐tryptophan	 with	 those	 of	 the
nickel	(II)	and	cobalt	(II)	complexes	are	useful	in	determining	the	atoms	of	the	ligand	that	are
coordinated	to	the	metal	ion.	In	addition,	K	(dissociation	constant)	and	ΔG	(Gibbs	free	energy)
values	 were	 calculated	 using	 the	 Babko	 and	 Stanley	 &	 Turners	methods.	 Antibacterial	 and
antifungal	activities	of	 the	complexes	were	studied	screened	against	bacteria	and	fungi.	The
activity	data	shows	that	and	cobalt	complexes	of	DL‐tryptophan	are	more	potent	than	the	DL‐
tryptophan.	
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1.	Introduction	
	
DL‐Tryptophan	(Abbreviated	as	Trp	or	W,	C11H12N2O2,	MW:	
204.23	g/mol,	melting	point:	295	oC	[1]),	one	of	the	20	standard	
and	an	essential	amino	acid,	 is	encoded	 in	genetic	code	as	 the	
codon	UGG.	It	is	a	heterocyclic	compound	that	is	found	in	small	
amounts	 in	 most	 proteins.	 Only	 the	 L‐stereoisomer	 of	
tryptophan	 is	 commonly	 found	 in	 proteins,	 however	 the	 D‐
stereoisomer	 is	 occasionally	 noted	 in	 naturally	 occurring	
peptides	(for	example,	the	marine	venom	peptide	contryphan)	
[2].	The	distinguishing	structural	characteristic	of	tryptophan	is	
that	 it	 contains	 an	 indole	 functional	 group.	 The	 isolation	 of	
tryptophan	 was	 first	 reported	 by	 Hopkins	 in	 1901	 through	
hydrolysis	of	casein	[3].	
DL‐Tryptophan	plays	an	 important	 role	 in	 the	growth	and	
development	of	infants	and	in	the	biosynthesis	of	serotonin	[4]	
and	 niacin	 [5]	 (deficiency	 of	 niacin	 or	 tryptophan	 can	 cause	
pellagra).	 Its	 occurrence	 in	 milk	 has	 been	 suggested	 as	 the	
reason	that	drinking	milk	before	bed	 time	helps	sleeping.	 It	 is	
used	 in	 medicinal	 [6‐9]	 and	 nutritional	 research,	 in	 enriched	
foods,	and	as	a	dietary	supplement	[10,11].	
Computational	 [12],	 gravimetric	 [13,14],	 titrimetric	 [15],	
electrochemical	 [16],	spectrophotometric	and	kinetic	methods	
[17‐36]	were	used	to	determine	tryptophan	in	the	presence	of	
various	 metals.	 For	 example,	 in	 the	 previous	 study	 of	 DL‐
tryptophan	 [33],	 polarographic	 studies	 of	 nickel	 (II)	 +	 DL‐
tryptophan	solutions	were	reported.		
In	this	work,	the	polarography	of	nickel	 in	the	presence	of	
DL‐tryptophan	 has	 been	 studied	 in	 KNO3	 supporting	
electrolyte.	Nickel	yielded	two	irreversible	steps	which	are	due	
to	 the	 formation	 of	 two	 varieties	 of	 the	 complex	 in	 sluggish	
equilibrium	with	 each	 other.	 The	 reduction	 is	 an	 irreversible,	
kinetically	 controlled	 process	 as	 evidenced	 from	 cyclic	
voltametry	and	i‐t	curves.	
From	 the	 literature	 studies,	 there	 are	 no	experiments	 on	
the	 synthesis,	 the	 determination	 of	 optimum	 conditions,	 the	
spectral	analyses	 and	 the	assignment	of	dissociation	constant.	
Therefore,	 in	 the	 present	 study,	 as	 a	 contribution	 for	 the	
literature,	nickel	 (II)	 and	cobalt	 (II)	 complexes	of	 racemic	DL‐
tryptophan	were	 synthesized	 and	 analyzed	 by	 using	 physico‐
chemical,	 spectroscopic	 and	 potentiometric	 titration	
techniques.	 Optimum	 conditions	 and	 the	 molar	 ratio	 for	 the	
reaction	 were	 determined	 by	 spectral	 measurements.	 In	
addition,	 their	 antibacterial	 and	 antifungal	 activities	 were	
studied.	
	
2.	Experimental	
	
2.1.	Material	and	measurements	
	
All	reagents	were	purchased	from	commercial	sources	and	
used	 as	 supplied.	 Elemental	 analyses	 for	 C,	 H	 and	 N	 were	
performed	 with	 a	 Costech	 elemental	 analyzer.	 Conductivity	
measurements	 were	 obtained	 in	 DMSO	 using	 an	 Inolab	
Thermal	 740P.	 The	 magnetic	 susceptibilities	 were	 measured	
MK‐1	 Sherwood	 scientific	 magnetic	 susceptibility	 balance.	
UV/Vis	 spectra	 were	 measured	 with	 a	 Shimadzu	 UV‐1700	
Pharma	 spectrophotometer	 in	 the	 200‐800	 nm	 range.	 IR	
spectra	 were	 recorded	 with	 a	 Shimadzu	 IR‐470	
spectrophotometer	as	KBr	pellets	 in	 the	frequency	range	400‐
4000	 cm‐1.	 Shimadzu	 XRD‐6000	 was	 employed	 for	 the	 XRD	
analyses.	 All	 pH	 measurements	 were	 obtained	 using	 a	
calibrated	 Metrohm	 654	 digital	 pH	 meter	 with	 a	 Sensorex	
combination	 pH	 glass	 electrode	 assembly.	 The	 pH	meter	was	
calibrated	daily	before	use	with	pH	=	4	and	7	Metrohm	AG	CH	
9100	Hersau	 buffers.	Metrohm	Multi‐Burette	 E‐845	was	 used	
as	the	burette.	
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2.2.	Synthesis	of	nickel	(II)	and	cobalt	(II)	complexes	of	DL‐
tryptophan	
	
A	 solution	of	DL‐tryptophan	 (0.102	 g,	 0.5	mmol)	 in	water	
was	added	drop‐wise	to	a	solution	of	NiCl2.6H2O	or	CoCl2.6H2O	
in	water	 at	 the	mole	 ratio	 of	 1:1.	 The	 pH	 of	 the	 solution	was	
adjusted	to	~7	by	adding	0.1	M	NaOH	in	water	and	the	system	
was	refluxed	for	two	hours.	The	obtained	solid	materials	were	
washed	with	water,	and	dried.	The	complexes	were	completely	
soluble	only	in	DMSO.	
Nickel	complex	of	DL‐tryptophan:	Colour:	Very	light	green.	
Yield:	 82%.	 M.p.:	 264.6	 °C.	 Anal.	 calcd.	 for	 [C11H12N2O2.NiCl2	
(H2O)2].4	H2O:	 C,	 64.70;	H,	 5.88;	N,	 13.72.	 Found:	 C,	 63.88;	H,	
6.04;	 N,	 14.07%.	 Magnetic	 moment	 (μeff,	 BM):	 3.88.	 UV/Vis	
bands	 (nm):	 290,	 511.	 FT‐IR	 (KBr,	,	 cm‐1):	 3422	 (νO‐H),	 3235	
(νN‐H),	 1766	 (νC=O),	 1667	 (νC‐N),	 1472	 (νCH),	 1350	 (νCH2),	 1130	
(νC‐O).		
Cobalt	 complex	 of	DL‐tryptophan:	 Colour:	 Very	 light	 pink.	
Yield:	 83%.	 M.p.:	 264.4	 °C.	 Anal.	 calcd.	 for	 [C11H12N2O2.CoCl2	
(H2O)2].4	H2O:	 C,	 64.70;	H,	 5.88;	N,	 13.72.	 Found:	 C,	 64.22;	H,	
6.04;	 N,	 14.04%.	 Magnetic	 moment	 (μeff,	 BM):	 4.80.	 UV/Vis	
bands	 (nm):	 287,	 486.	 FT‐IR	 (KBr,	,	 cm‐1):	 3424	 (νO‐H),	 3237	
(νN‐H),	 1769	 (νC=O),	 1667	 (νC‐N),	 1475	 (νCH),	 1353	 (νCH2),	 1132	
(νC‐O).	
	
2.3.	General	procedure	
	
In	 the	 spectroscopic	 studies,	 in	 order	 to	 determine	 the	
wavelength	 which	 would	 be	 used	 in	 the	 reaction,	 various	
solutions	 including	 DL‐tryptophan	 in	 presence	 nickel	 (II)	 or	
cobalt	(II)	between	pH	=	1‐10	were	prepared	in	the	proportion	
of	1:1	and	the	spectra	were	measured	after	waiting	for	10	min.	
As	 a	 result	 of	 the	 investigation	 at	 various	 the	 pH	 range,	 the	
nickel	 and	 cobalt	 complexes	 of	 DL‐tryptophan	 showed	
absorption	 peaks	 at	 λ	 =	 511	 and	 486	 nm,	 respectively.	 We	
observed	that	the	wavelength	values	changed	very	little	in	the	
pH	 range	 6~7	 and	 a	 pH	 value	 of	 7	 was	 chosen	 for	 all	
experiments	at	room	temperature.	
In	 the	 potentiometric	 titration	 studies,	 the	 solutions	
including	 HClO4,	 HClO4	 +	 DL‐tryptophan	 and	 HClO4	 +	 DL‐
tryptophan	 +	 Ni(II)	 or	 Co(II)	 solutions	 were	 titrated	
potentiometrically	 by	 using	 NaOH	 (0.1	 N).	 The	 results	 are	
demonstrated	in	Figures	1a	and	1b.	
	
3.	Result	and	discussion	
	
3.1.	Optimization	of	reactions	
	
In	order	to	determine	the	optimum	conditions	which	would	
be	 used	 in	 the	 subsequent	 reaction,	 the	 effect	 of	 pH,	
temperature,	 time	 and	 concentrations	 on	 the	 reactions	 was	
studied.	
The	effect	of	pH	was	studied	in	the	range	1‐10	by	adjusting	
the	pH	with	HClO4	and	NaOH	solutions.	The	general	procedure	
was	 applied	 and	 the	 absorbance	 was	 measured	 by	 UV‐VIS	
spectrometer.	The	results	are	shown	in	Figure	2.	A	pH	value	of	
7	was	chosen	as	the	optimum	in	two	reactions.	
The	effect	of	temperature	on	the	reaction	was	observed	for	
eight	different	temperatures	under	the	general	procedure.	The	
highest	 absorbance	 was	 determined	 at	 room	 temperature	 as	
shown	Figure	3.	
The	effect	of	time	on	the	reaction	was	observed	from	5	min	
to	 50	 min	 and	 the	 general	 procedure	 was	 applied.	 Optimum	
results	were	obtained	at	40	min.	The	absorbance	was	found	to	
be	stable	for	at	least	40	min	as	shown	in	Figure	4.	According	to	
these	results	reactions	are	completed	after	40	min.	
The	 effect	 of	 the	 concentration	 of	 DL‐tryptophan	 in	 the	
presence	 of	 nickel	 (II)	 or	 cobalt	 (II)	 was	 investigated	 in	 the	
range	 1x10‐3‐1x10‐2	 M	 under	 the	 general	 procedure.	
Concentrations	 of	 1x10−2	 M	 were	 chosen	 as	 the	 optimum	
(Figure	 5).	 According	 to	 this	 Figure	 5,	 the	 reactions	 are	 in	
favour	of	products.	
3.2.	Composition	and	dissociation	constants	of	complexes	
	
Job’s	 method	 of	 continuous	 variations	 [36]	 and	 the	
methods	of	Babko	[37]	and	Turner	&	Anderson	[38]	were	used	
in	 the	 investigation	of	 the	composition	and	stability	 constants	
of	the	complex	during	the	reaction.		
	
(a)	
	
(b)	
	
Figure	1.	DL‐Tryptophan	+	Ni	(II)	(a);	DL‐Tryptophan	+	Co	(II)	(b).	
	
	
	
Figure	2.	Effect	of	pH.	
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Figure	3.	Effect	of	temperature.	
	
	
Figure	4.	Effect	of	time.	
	
	
Figure	5.	Effect	of	concentration.	
	
Various	solutions	were	prepared	at	total	concentrations	of	
1	 x	 10‐3	 M,	 under	 the	 general	 procedure,	 including	 DL‐
tryptophan	and	nickel	 (II)	 or	 cobalt	 (II).	Firstly,	 the	perpetual	
change	 graph	 was	 plotted	 after	 necessary	 absorbance	
adjustment	was	made	and	demonstrated	Figure	6.	
	
Figure	6.	Determination	of	mole	ratio.	
	
Secondary,	 dilution	 curves	 were	 drawn	 fort	 the	
determination	 of	 stability	 constants	 with	 help	 solutions	 that	
give	 equal	 absorption	 [37‐39].	 The	 measured	 absorbance	
values	 of	 DL‐tryptophan	 with	 nickel	 (II)	 and	 cobalt	 (II)	
solutions	 at	 different	 concentrations	 were	 shown	 in	 Table	 1.	
The	plots	of	Absorbance	(nm)	against	[Ni(II))	or	Co(II)]	=	[DL‐
tryptophan]	are	linear.	
	
Table	1.	The	values	of	dilution	curves.	
[Ni2+]/[Ni2+]		
+	[DL‐tryptophan]	(M)	
A511	
(nm)	
[Co2+]/[Co2+]		
+	[D,L‐tryptophan]	(M)	
A486	
(nm)	
8.0x10‐5	 0.070 8.0x10‐5	 0.058
1.6x10‐4 0.140 1.6x10‐4	 0.128
2.4x10‐4	 0.222	 2.4x10‐4	 0.210	
3.3x10‐4 0.300 3.3x10‐4	 0.288
4.2x10‐4	 0.380	 4.2x10‐4	 0.368	
	
Job’s	 method	 of	 continuous	 variations	 [37]	 demonstrated	
one	maximum	 for	 [Ni2+]/{[Ni2+]	+	 [D,L‐tryptophan]	 }=	0.5	 and	
one	 maximum	 for	 [Co2+]/{[Co2+]	 +	 [D,L‐tryptophan]}	 =	 0.5	 in	
Figure	 6,	 one	 molecule	 of	 DL‐tryptophane	 reacts	 with	 one	
molecule	 nickel(II)	 ion	 andone	 molecule	 of	 DL‐tryptophan	
reacts	with	one	molecule	cobalt(II)	ion.	
In	 the	 1:1	 stoichiometric	 reactions,	 the	 stability	 constant	
formula	[38,39]	are		
	
K=	x/(a1‐x))	(b1‐x))	=	x/(a2	‐x)(b2‐x)	and	x	=a2	b2	‐	a1	b1	/	a2	‐	a1+	b2	‐	a1	 						(1)	
	
where	the	a’s	and	b’s	denote	initial	concentration	of	nickel	(II)	
or	cobalt	 (II)	and	DL‐tryptophan,	respectively,	Where	a1	 is	the	
concentration	 of	 nickel	 or	 cobalt	 and	 is	 calculated	 from	 [M2+]	
/[M2+]	 +	 [DL‐tryptophan],	 b1	 is	 the	 concentration	 of	 DL‐
tryptophan	 and	 is	 computed	 from	 [M2+]+[DL‐tryptophan]	 =	
1x10‐3	 M.	 Further,	 a2	 andb2	 are	 [M2+]	 and	 [DL‐tryptophan],	
respectively.	 They	 are	 calculated	 from	 dilution	 curves	 (M+2	 =	
Ni2+	 or	 Co2+),	 and	 x	 denotes	 the	 concentration	 of	 the	 complex	
formed.	 K	 values	 calculated	 by	 this	 method	 are	 of	 the	 same	
order	of	magnitude	as	those	obtained	by	the	first	method.	The	
values	 of	 K	 (dissociation	 constant)	 for	 the	 reactions	 of	 DL‐
tryptophan	 with	 nickel	 (II)	 or	 cobalt	 (II)	 were	 calculated	 by	
means	of	the	above	equations.	
The	Gibbs	free	energy	of	formation	of	the	complex	may	be	
calculated	readily	from	the	relation	
	
ΔG	=	‐R.T.lnK	 	 	 	 	 			(2)	
	
where	 R	 is	 gas	 constant	 (1.987	 cal/mol.K),	 T	 is	 temperature	
(273.16	+	20	=	293.16	K)	and	K	is	stability	constant.	The	values	
of	 K	 (Stability	 Constant)	 and	 ΔG	 (Gibbs	 free	 energy)	 for	 the	
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reactions	DL‐tryptophan	with	nickel	or	cobalt	were	calculated	
by	means	of	above	equations.	
	
3.3.	Synthesis	and	analyses	
	
Nickel	 (II)	 and	 cobalt	 (II)	 metal	 complexes	 of	 DL‐
tryptophan	 were	 synthesized	 in	 water	 under	 refluxing	
conditions.	 High	 yields	 were	 obtained	 (over	 80	 %).	 Both	
complexes	are	air	stable	and	soluble	only	in	DMSO.	
When	 the	 elemental	 analyses	 of	 the	 complexes	 were	
investigated,	 the	calculated	and	found	ratios	were	 found	to	be	
1:1	in	the	complexes	of	DL‐tryptophan	in	the	presence	of	nickel	
(II)	 or	 cobalt	 (II).	 The	 elemental	 analyses	 indicate	 that	 all	 the	
metal	complexes	have	1:1	stoichiometry.	The	magnetic	moment	
values	for	nickel	(II)	and	cobalt	(II)	complexes	are	in	the	range	
of	3.88	and	4.80	BM,	respectively,	indicating	that	the	nickel	(II)	
and	cobalt	(II)	complexes	are	typically	high	spin	complexes	and	
having	 octahedral	 structure.	 According	 to	 specific	 and	
equivalent	 conductivity	 values	 (Table	 2)	 obtained	 for	 these	
complexes,	 while	 specific	 values	 of	 DL‐tryptophan	 in	 the	
presence	 of	 nickel	 (II)	 and	 cobalt	 (II)	 increase	 with	
concentration,	 the	 equivalent	 conductivity	 values	 decrease.	
These	 results	 show	 the	 presence	 of	 ions	 belonging	 to	 the	
system.	In	addition,	when	Figures	1a	and	1b	is	investigated,	DL‐
tryptophan	 and	 DL‐tryptophan	 +	 M2+	 (M2+	 =	 Ni2+	 or	 Co2+)	
curves	 appeared	 different	 places	 and	 complexation	 had	
occurred.	
	
Table	2.	Specific	and	equivalent	conductivity	values	of	DL‐tryptophan	with	
M	(II)	(M:	Ni	or	Co).	
C	(M)	 Specific	conductivity,	
L	(s/cm)	x	10‐6	
Equivalent	conductivity,	Λ
0.01	 1027	(1789)	 102.7	(178.9)	
0.02	 1440	(2205)	 72.0	(110.2)
0.03	 1870	(2636)	 62.0	(87.8)	
0.04	 2300	(3065)	 57.5	(76.6)	
0.05	 2720	(3485)	 54.4	(69.7)	
	
The	 UV/Vis	 spectra	 of	 free	 DL‐tryptophan	 molecule	
displays	an	absorption	band	at	302	nm,	whereas	the	complexes	
display	a	number	of	distinct	bands	at	290	and	511	nm	for	DL‐
tryptophan	 +	 nickel	 (II),	 and	 287	 and	 486	 nm	 for	 DL‐
tryptophan	+	cobalt	(II).	The	absorption	bands	at	290	and	287	
nm	are	attributed	to	π‐π*	transitions.	The	high	energy	bands	at	
511	and	486	nm	originated	from	the	d‐d	transitions.	
The	 IR	 spectra	 of	 the	 free	 ligand	 (DL‐tryptophan)	 and	 its	
metal	 complexes	 are	 interpreted	 by	 comparing	 the	 spectra	 of	
the	 complexes	 with	 that	 of	 the	 free	 ligand.	 The	 infrared	
spectrum	 of	 DL‐tryptophan	 results	 are	 listed	 in	 Table	 3.	 The	
comparison	 of	 the	 band	 positions	 of	 various	 vibrations	 are	
ascertained	 with	 good	 evidence.	 In	 the	 infrared	 spectrum	 of	
complexes,	 two	 bands	 centered	 at	 3422	 and	 3235	 cm‐1	 for	
nickel	 (II)	 complex	 and	 3424	 and	 3237	 cm‐1	 for	 cobalt	 (II)	
complex	 are	 attributed	 to	 the	 ν(OH)	 and	 ν(NH)	 vibrations	 of	 the	
lattice	water	molecule	 and	 the	amine	group,	 respectively.	The	
broadness	 of	 these	 bands	 indicates	 hydrogen	 bonding.	 The	
sharp	bands	at	about	1760	cm‐1	are	assigned	to	the	absorption	
of	 the	 carbonyl	 group.	 The	 ν(C‐N)	 and	 ν(C‐O)	 stretchings	 of	 the	
complexes	 are	 found	 in	 the	 frequency	 range	 about	 1660	 and	
1160	 cm‐1,	 respectively,	 other	 vibrations	 are	 observed	 for	
nickel	 (II)	 at	 1472	 ν(CH)	 and	 1350	 ν(CH2),	 and	 for	 cobalt	 (II)	 at	
1475	ν(CH)	and	1353	ν(CH2),	respectively.	
	
Table	3.	Selected	FT‐IR	data	for	DL‐tryptophan.	
Assignment	 	 DL‐tryptophan,	frequencies,	cm‐1	
ν(OH)	 3408	
ν(NH)	 3220	
ν(COOH)	 1756	
ν(C‐N)	 1655	
ν(CH)	 1411	
ν(CH2)	 1315	
ν(C‐O)	 1142	
	
	The	 XRD	 (Powder	 Pattern)	 spectra	 of	 the	 complexes	 are	
indexed	 by	 an	 X‐Ray	 diffractometer	 (Figure	 7	 and	 8).	 Three	
peaks	 are	 determined	 for	 both	 complexes	 at	 5.2300,	 14.9200	
and	 19.5600	 (2θ)	 and	 the	 interplanar	 spacing	 (d)	 has	 been	
calculated	as	16.97784,	5.93296	and	4.53476,	respectively.	All	
the	 important	 peaks	 have	 been	 indexed	 and	 the	 observed	
values	 of	 the	 interplanar	 distance	 are	 compared	 with	 the	
calculated	 ones.	 The	 presence	 of	 the	 forbidden	 number	
confirms	the	tetragonal	system.	This	implies	that	nickel	(II)	and	
cobalt	(II)	complexes	are	distorted	octahedral	in	structure.	
	
	
Figure	7.	The	XRD	Spectrum	of	DL‐tryptophan	in	the	presence	of	Ni	(II).
	
	
	
Figure	8.	The	XRD	Spectrum	of	DL‐tryptophan	in	the	presence	of	Co	(II).
	
The	 synthesized	 complexes	 are	 estimated	 for	 their	
microbial	 toxicity	 against	 a	 set	of	bacterial	 and	 fungal	 strains.	
The	 antibacterial	 activity	 of	 the	 complexes	 is	 tested	using	 the	
agar	 well‐diffusion	method	 [40],	 and	 the	 results	 are	 given	 in	
Table	 4.	 The	 results	 show	 that	 the	 complex	 has	 significant	
antibacterial	activity.	
	
Table	4.	The	antibacterial	activities	of	the	complexes	and	standard	*.			
Bacteria	
Zone	of	inhibition,	mm	
Nickel	(II)	
complex	
Cobalt	(II)	
complex	
Standard	drug		
(Imipenem,	10	µg/disc)	
Gram	positive	bacteria
Bacillus	
subtilis	
25 25 30	
Staphylococcus	
aureus	
25	 25	 33	
Gram	negative	bacteria
Escherichia	
coli
20 20 32	
Pseudomonas	
aeruginosa	
25	 22	 30	
*	Concentration	of	sample	is	3	mg/mL	of	DMSO.	
	
The	 antifungal	 test	 is	 caried	 out	 by	 using	 the	 agar	 tube	
dilution	 protocol	 method	 [41].	 The	 antifungal	 results	 of	 the	
synthesized	complexes	are	given	in	Table	5.	According	to	Table	
5,	complex	shows	significant	antifungal	activity.	
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Scheme	1
	
	
	
Table	5.	The	antifungal	activities	of	the	complexes	and	standard	a.	
Fungus	
Inhibition,	%	 	 	
Nickel	(II)	
complex	
Cobalt	(II)	
complex	
Standard	
drug	a	
MIC	b,	
µg/mL	
Candida	
albicans	
75	 75 Miconazole 110
Candida	
glaberata	
40	 50 Miconazole 73
Fusarium	
solani	
70	 75	 Miconazole	 110	
a	Incubation	temperature:	27	°C.	
b	Concentration	of	sample	200	µg/mL	of	DMSO.	
	
4.	Conclusion	
	
According	 to	 spectrophotometric	 and	 potentiometric	
titration	results,	the	reactions	of	DL‐tryptophan	with	nickel	(II)	
or	cobalt	 (II)	are	complexation	reactions.	One	molecule	of	DL‐
tryptophan	 reacts	with	 one	molecule	 nickel	 (II)	 or	 cobalt	 (II)	
ion.	 K	 (dissociation	 constant)	 values	 are	 calculated	 from	
perpetual	change	and	dilution	curves	as	112201	and	‐6773.41	
cal/mol	for	nickel(II)	+	DL‐tryptophan	and	30549	and	‐6015.57	
cal/mol	 for	 cobalt(II)	 +	 DL‐tryptophan,	 respectively.	 The	
negative	 values	 of	 ΔG	 mean	 that	 the	 kinetic	 process	 is	 a	
spontaneous	one.	The	DL‐tryptophan	and	nickel	(II)	and	cobalt	
(II)	 complexes	 are	 found	 to	 be	 active	 against	 some	 of	 the	
representative	 bacterial	 and	 fungal	 strains.	 The	 possible	
reaction	mechanism	is	given	in	Scheme	1.		
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